News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

Katherine Talcott, MD

Ophthalmologist at Cleveland Clinic in Cleveland, Ohio

Articles by Katherine Talcott, MD

A review of the DAVIO 2 phase 2 trial results

ByKatherine Talcott, MD

July 9th 2025

A hope for reducing treatment burden for wet age-related macular degeneration with a sustained-release vorolanib intravitreal insert

Latest Updated Articles

A review of the DAVIO 2 phase 2 trial results
Published: July 9th 2025 | Updated:

Trending on Modern Retina

EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME

AAO 2025: Inder Paul Singh, MD, shares his experience with the Academy Technician Training Platform

Retina roundup: October 13 to October 17

© 2025 MJH Life Sciences^®

All rights reserved.